Back to
CIBC Private Wealth Group LLC
IOVA
Showing 2 of 4 quarters
Position history for
CIBC Private Wealth Group LLC's holdings in Iovance Biotherapeutics, Inc.
No. CIBC Private Wealth Group exited its IOVA (Iovance Biotherapeutics) position in Q3 2025. Its Q2 2025 13F listed 165 shares worth $284. CIBC Private Wealth Group first reported IOVA in Q1 2024 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$284
Total Shares Change
-165
Quarter-by-Quarter History